Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)
Historic Interest Coverage Ratio for Gyre Therapeutics (GYRE) over the last 10 years, with Q1 2024 value amounting to 25.62.
- Gyre Therapeutics' Interest Coverage Ratio rose 14722.52% to 25.62 in Q1 2024 from the same period last year, while for Dec 2024 it was 51.31, marking a year-over-year increase of 14907.49%. This contributed to the annual value of 25.92 for FY2023, which is 48694.61% down from last year.
- Latest data reveals that Gyre Therapeutics reported Interest Coverage Ratio of 25.62 as of Q1 2024, which was up 14722.52% from 10.36 recorded in Q1 2023.
- In the past 5 years, Gyre Therapeutics' Interest Coverage Ratio registered a high of 25.62 during Q1 2024, and its lowest value of 2300.0 during Q3 2020.
- In the last 3 years, Gyre Therapeutics' Interest Coverage Ratio had a median value of 183.23 in 2020 and averaged 660.21.
- Examining YoY changes over the last 5 years, Gyre Therapeutics' Interest Coverage Ratio showed a top increase of 14722.52% in 2024 and a maximum decrease of 14722.52% in 2024.
- Over the past 3 years, Gyre Therapeutics' Interest Coverage Ratio (Quarter) stood at 376.82 in 2020, then surged by 102.75% to 10.36 in 2023, then soared by 147.23% to 25.62 in 2024.
- Its Interest Coverage Ratio stands at 25.62 for Q1 2024, versus 10.36 for Q1 2023 and 376.82 for Q4 2020.